Buy & Sell Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) – Bio-Rad Laboratories, Inc. Class A Common Stock Price Today
Key Stats
- $7.57BMarket Cap
- HealthSector
- -20.57%3M Drawdown
- $7.42BEnterprise Value
- -Dividend Yield
- 61 daysTypical Hold Time
Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) is currently valued at a market capitalization of $7.57B, with an enterprise value of $7.42B. Over the past 52 weeks, Bio-Rad Laboratories, Inc. Class A Common Stock has traded between a low of $216.56 and a high of $339.75, highlighting its annual price range. Over the past three months, Bio-Rad Laboratories, Inc. Class A Common Stock has recorded a drawdown of -20.57%, reflecting recent price volatility. Bio-Rad Laboratories, Inc. Class A Common Stock offers a dividend yield of -. On average, investors hold Bio-Rad Laboratories, Inc. Class A Common Stock for approximately 61 days, indicating typical investor behavior on the platform.
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
